The Interterritorial Health Council has agreed this Thursday to resume vaccination with AstraZeneca doses, which had been interrupted as a "precaution", after detecting some cases of thrombi in patients who had received that vaccine. As announced by the Minister of Health, Carolina Darias, it will be applied again from Wednesday of next week, based on reports from the European Medicines Agency.
According to this body, "a causal relationship cannot be confirmed" between the specific thromboembolic events reported in recent days and the administration of the AstraZeneca vaccine, although "it cannot be ruled out either" that cause/effect relationship with the available data, so the investigation will continue. "The benefits greatly outweigh the risks of the vaccine," stressed the director of this body in Spain.
In addition, the Canary Islands expects to have an "important" supply of doses of the Johnson & Johnson vaccine, better known as Janssen, starting next April, following the validation of said single-dose vaccine by the European Union. This was reported at a press conference by the Minister of Health, Blas Trujillo, who indicated that these vaccines will be added to the "also considerable" increase that has been announced in recent days in the supply of the Pfizer vaccine.
Blas Trujillo indicated that this will make it possible to continue with the rate of vaccination in the Canary Islands, which was paralyzed as a result of the scientific analyzes that were being carried out as a result of the alleged side effects of AstraZeneca.
